{
    "clinical_study": {
        "@rank": "75370", 
        "brief_summary": {
            "textblock": "This protocol will investigate the neurobiological underpinnings of alcohol craving in\n      recently detoxified alcoholic drinkers utilizing novel functional brain imaging. This\n      clinical magnetic resonance spectroscopy (MRS) study will investigate whether glutamate and\n      other brain metabolites correlate to measures of alcohol craving severity"
        }, 
        "brief_title": "MRS Probe Study of Alcohol", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heavy Dose Drinkers", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:    (Minimal or No Alcohol Group)\n\n          1. Male or female age 21-70\n\n          2. Consume less alcohol then what is described in this protocol as a \"higher dose\n             drinker\", or consume no alcohol at all.\n\n          3. Able to complete a 60 min. MRS brain scan.\n\n        Exclusion Criteria:\n\n          1. Inability to speak English\n\n          2. Inability or unwillingness to provide written informed consent\n\n          3. Diagnosis of active substance dependence other than nicotine (e.g. alcohol, cannabis,\n             caffeine, prescription use of barbiturates, benzodiazepines, opiates, or stimulants)\n             this will be determined using a PRISM (Psychiatric Research Interview for Substance\n             and Mental Disorders) interview.\n\n          4. Any unstable active medical or additional psychiatric condition as determined by the\n             investigator\n\n          5. Active suicidal ideation as determined by the PHQ-9 question 9 indicating response #2\n             or higher (several days; more than half the days; or nearly every day).\n\n          6. History of encephalopathy, hepatic failure, or HIV seropositivity\n\n          7. History of claustrophobia\n\n          8. History of major head trauma with loss of consciousness >5 minutes or skull fracture\n\n          9. History of previous neurological event (e.g. epilepsy, stroke, transient ischemic\n             attack)\n\n         10. Implanted metal objects (e.g. pacemakers; aneurysm clips; metal prostheses, joints,\n             rods, or plates)\n\n         11. Contraindication to MRI scanning\n\n         12. Pregnancy or breast-feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679444", 
            "org_study_id": "12-003693"
        }, 
        "intervention": {
            "intervention_name": "Magnetic Resonance Spectroscopy", 
            "intervention_type": "Procedure", 
            "other_name": "MRS"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "MRS", 
            "Heavy dose drinkers", 
            "Alcohol", 
            "NIAAA"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Magnetic Resonance Spectroscopy Probe Study of Alcohol Use", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Mark Frye, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "assessing baseline perturbations in anterior cingulate and ventral striatal metabolites (NAA levels, glutamate levels, glutamine levels)", 
            "measure": "Utilizing Magnetic Resonance Spectroscopy at 3 Tesla, investigate the neurobiological underpinnings of alcohol craving", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679444"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Mark Frye", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Evaluate the relationship between these metabolites, each reported as a Cerebrospinal fluid-corrected absolute concentration, and severity of alcohol cravings, as measured primarily by the Penn Alcohol Craving Scale and secondarily by the Inventory of Drug Taking Situations.", 
            "measure": "Evaluate the relationship between these metabolites, each reported as a Cerebrospinal Fluid-corrected absolute concentration, and severity of alcohol cravings", 
            "safety_issue": "No"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}